Clinical Trial Update: Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating phytocannabinoids for chemotherapy-induced peripheral neuropathy in breast and colon cancer survivors has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Chemotherapy-induced Peripheral Neuropathy
• Colon Cancer

Drugs mentioned

• Phytocannabinoids (phytocannabinoids)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Breast Carcinoma, Chemotherapy-Induced Peripheral Neuropathy | EARLY_Phase 1 | Status: WITHDRAWN